Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Supreme Court rejects Covidien bid to restore patent verdict against Ethicon

Written by: | no-reply@reuters.com | Dated: Monday, November 30th, 2015

 

In refusing to hear the case, the high court left in place a December 2014 ruling by the U.S. Court of Appeals for the Federal Circuit that threw out a judge’s finding that Ethicon had infringed upon Covidien’s patents for surgical cutting tools. Covidien is owned by Medtronic Plc.

In a separate patent case, the court declined to hear Biolitec AG’s challenge to a $70 million contempt finding relating to a patent dispute the company had with AngioDynamics Inc.

The court’s refusal to take the case means a March ruling by the 1st U.S. Circuit Court of Appeals in favor of AngioDynamics remains intact.

 

(Reporting by Lawrence Hurley; Editing by Will Dunham)

Source: Reuters Health

http://www.reuters.com/article/2015/11/30/us-usa-court-ip-idUSKBN0TJ1QH20151130

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2017 Focus: Ad Agency Roundtable and more!

Subscribe

Ad Right Bottom

Main Navigation